NFL Biosciences's gross profit for the
six
months ended in Dec. 2024 was €-1.19 Mil. NFL Biosciences's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was €-1.55 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. NFL Biosciences's gross profit for the
six
months ended in Dec. 2024 was €-1.19 Mil. NFL Biosciences's Revenue for the
six
months ended in Dec. 2024 was €0.00 Mil. Therefore, NFL Biosciences's Gross Margin % for the quarter that ended in Dec. 2024 was %.
NFL Biosciences had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
NFL Biosciences Gross Profit Historical Data
The historical data trend for NFL Biosciences's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NFL Biosciences's Gross Profit
For the Biotechnology subindustry, NFL Biosciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NFL Biosciences's Gross Profit Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NFL Biosciences's Gross Profit distribution charts can be found below:
* The bar in red indicates where NFL Biosciences's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.55 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
NFL Biosciences had a gross margin of % for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
NFL Biosciences Gross Profit Related Terms
Thank you for viewing the detailed overview of NFL Biosciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:ALNFL has been successfully added to your 